Brief: ExpreS2ion Awarded Grant For Developing New Platforms For Universal Mucosal Vaccines

ExpreS2ion Biotech Holding AB

03/03/2023 14:03

March 3 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES GRANT AWARD FOR THE DEVELOPMENT OF
NEW
PLATFORMS FOR UNIVERSAL MUCOSAL VACCINES
    * AWARD FUNDING COVERS 71% OF RESEARCH PROJECT AND AMOUNTS
TO DKK
29 MLN (APPROX. SEK 43 MLN), OF WHICH EXPRES(2)ION DIRECTLY IS
FUNDED WITH DKK 9.6 MLN (APPROX. SEK 14 MLN)
    * IFD INVESTMENT FUNDS 67% OF EXPRES2ION'S SHARE OF RESEARCH
PROJECT BUDGET
    * MUCOVAX CONSORTIUM AWARDED INNOVATION FUND DENMARK (IFD)
GRAND
SOLUTIONS GRANT FOR DEVELOPMENT OF NEW PLATFORMS FOR UNIVERSAL
MUCOSAL VACCINES IN 5-YEAR RESEARCH PROJECT

Source text for Eikon:  ID:nWkrRZZzT 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))